• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

μ-阿片受体基因敲除小鼠:μ-阿片受体在胃肠转运中的作用

mu-Opioid receptor-knockout mice: the role of mu-opioid receptor in gastrointestinal transit.

作者信息

Roy S, Liu H C, Loh H H

机构信息

Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

出版信息

Brain Res Mol Brain Res. 1998 May;56(1-2):281-3. doi: 10.1016/s0169-328x(98)00051-5.

DOI:10.1016/s0169-328x(98)00051-5
PMID:9602153
Abstract

The role of mu-opioid receptor in gastrointestinal transit was investigated using mu-opioid receptor knockout mice (MOR-KO). Our result establishes unequivocally that inhibition of GI transit by morphine is a mu-opioid receptor mediated function. In addition, we show that neither delta nor kappa receptor agonist given supraspinally or peripherally are able to inhibit GI transit in MOR-KO animals. It was interesting to observe that basal GI motility was lower in MOR-KO (-/-) compared to heterozygous (+/-) and wild type (+/+) animals.

摘要

利用μ-阿片受体基因敲除小鼠(MOR-KO)研究了μ-阿片受体在胃肠转运中的作用。我们的结果明确证实,吗啡对胃肠转运的抑制是一种由μ-阿片受体介导的功能。此外,我们还表明,无论是脊髓上还是外周给予δ或κ受体激动剂,均无法抑制MOR-KO动物的胃肠转运。有趣的是,观察到与杂合子(+/-)和野生型(+/+)动物相比,MOR-KO(-/-)动物的基础胃肠动力较低。

相似文献

1
mu-Opioid receptor-knockout mice: the role of mu-opioid receptor in gastrointestinal transit.μ-阿片受体基因敲除小鼠:μ-阿片受体在胃肠转运中的作用
Brain Res Mol Brain Res. 1998 May;56(1-2):281-3. doi: 10.1016/s0169-328x(98)00051-5.
2
Lack of mu-opioid receptor-mediated G-protein activation in the spinal cord of mice lacking Exon 1 or Exons 2 and 3 of the MOR-1 gene.在缺乏MOR-1基因外显子1或外显子2和3的小鼠脊髓中,μ-阿片受体介导的G蛋白激活缺失。
J Pharmacol Sci. 2003 Dec;93(4):423-9. doi: 10.1254/jphs.93.423.
3
Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.脊髓上的μ和δ以及外周的μ、δ和κ阿片受体的止泻特性:抑制腹泻而不导致便秘。
J Pharmacol Exp Ther. 1989 Apr;249(1):83-90.
4
Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.通过植入小球或泵给予的μ、κ或δ阿片类药物对口服沙门氏菌感染和胃肠道转运的影响。
Eur J Pharmacol. 2006 Mar 18;534(1-3):250-7. doi: 10.1016/j.ejphar.2006.01.048. Epub 2006 Mar 2.
5
Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.μ、δ和κ阿片受体在小鼠胃肠道转运效应和热板镇痛的脊髓及脊髓上介导中的作用。
J Pharmacol Exp Ther. 1984 Aug;230(2):341-8.
6
dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.右旋吗啡和左旋吗啡可减弱阿片δ和κ受体激动剂在μ阿片受体基因敲除小鼠中产生的镇痛作用。
Eur J Pharmacol. 2006 Feb 15;531(1-3):103-7. doi: 10.1016/j.ejphar.2005.12.012. Epub 2006 Jan 30.
7
Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice.正常小鼠和μ-阿片受体基因敲除小鼠的机械性撤反应特征以及μ、δ和κ阿片受体激动剂的作用
Brain Res. 1999 Mar 13;821(2):480-6. doi: 10.1016/s0006-8993(99)01060-4.
8
Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.μ、δ和κ阿片受体激动剂对大鼠可卡因辨别刺激特性的不同影响。
Eur J Pharmacol. 1997 Apr 11;324(1):21-9. doi: 10.1016/s0014-2999(97)00062-9.
9
MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions.μ-阿片受体基因敲除小鼠:μ-阿片受体在吗啡介导的免疫功能中的作用
Brain Res Mol Brain Res. 1998 Oct 30;61(1-2):190-4. doi: 10.1016/s0169-328x(98)00212-5.
10
Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.链脲佐菌素诱导的糖尿病选择性地改变了μ阿片受体激动剂产生的镇痛效力,但不影响δ和κ阿片受体激动剂产生的镇痛效力。
Brain Res. 1992 Feb 7;571(2):199-203. doi: 10.1016/0006-8993(92)90655-s.

引用本文的文献

1
The impact of opioid administration on the incidence of postanaesthetic colic in horses.阿片类药物给药对马麻醉后绞痛发生率的影响。
Front Pain Res (Lausanne). 2024 Feb 19;5:1347548. doi: 10.3389/fpain.2024.1347548. eCollection 2024.
2
Opioids in the Treatment of Chronic Idiopathic Diarrhea in Humans-A Systematic Review and Treatment Guideline.阿片类药物治疗人类慢性特发性腹泻——一项系统评价与治疗指南
J Clin Med. 2023 Mar 24;12(7):2488. doi: 10.3390/jcm12072488.
3
Changes to gut amino acid transporters and microbiome associated with increased E/I ratio in Chd8 mouse model of ASD-like behavior.
自闭症样行为 Chd8 小鼠模型中 E/I 比值增加与肠道氨基酸转运体和微生物组变化的关系。
Nat Commun. 2022 Mar 3;13(1):1151. doi: 10.1038/s41467-022-28746-2.
4
Perioperative and long-term outcomes of spontaneous ventilation video-assisted thoracoscopic surgery for non-small cell lung cancer.非小细胞肺癌自主通气电视辅助胸腔镜手术的围手术期及长期结局
Transl Lung Cancer Res. 2021 Oct;10(10):3875-3887. doi: 10.21037/tlcr-21-629.
5
The Guts of the Opioid Crisis.阿片类药物危机的核心问题
Physiology (Bethesda). 2021 Sep 1;36(5):315-323. doi: 10.1152/physiol.00014.2021.
6
LP1 and LP2: Dual-Target MOPr/DOPr Ligands as Drug Candidates for Persistent Pain Relief.LP1 和 LP2:作为治疗持续性疼痛候选药物的双重靶向 MOPr/DOPr 配体。
Molecules. 2021 Jul 8;26(14):4168. doi: 10.3390/molecules26144168.
7
Experimental considerations for the assessment of in vivo and in vitro opioid pharmacology.评估体内和体外阿片类药物药理学的实验考虑因素。
Pharmacol Ther. 2022 Feb;230:107961. doi: 10.1016/j.pharmthera.2021.107961. Epub 2021 Jul 10.
8
Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.阿片类药物引起的便秘和肠道功能障碍的管理:意大利多学科专家组的专家意见。
Adv Ther. 2021 Jul;38(7):3589-3621. doi: 10.1007/s12325-021-01766-y. Epub 2021 Jun 4.
9
Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility.Toll 样受体 4(TLR4)/阿片受体通路串扰及其对阿片类药物镇痛、免疫功能和胃肠道动力的影响。
Front Immunol. 2020 Jul 8;11:1455. doi: 10.3389/fimmu.2020.01455. eCollection 2020.
10
Opioids and Cancer Mortality.阿片类药物与癌症死亡率。
Curr Treat Options Oncol. 2020 Feb 20;21(3):22. doi: 10.1007/s11864-020-0713-7.